Introduction: This paper reports the 1-year results of the first 2 cases of macular translocation in Singapore.Clinical Picture: A 66-year-old female and a 45-year-old male Chinese presented with subfoveal choroidal neovascularisation (CNV) in their right eyes. The woman’s condition was secondary to pathological myopia while the man’s was idiopathic. Their preoperative best-corrected visual acuities were 6/15-2 and 6/30, respectively.Treatment: Both patients underwent macular translocation with punctate retinotomies and chorioscleral infolding (limited macular translocation) in their affected eye.Outcome: Both patients achieved effective macular translocation postoperatively. Their CNVs became extrafoveal and were ablated with conventional laser photocoagulation in the early postoperative period. They did not recur and their visual acuities improved to 6/9-1 and 6/12 at 1 year postoperatively, respectively.Conclusion: Macular translocation is a new treatment modality that offers patients with subfoveal CNV a chance of improving their vision, potentially to a level that may allow reading and driving.
Choroidal neovascularisation (CNV) is a devastating complication of macular degeneration and a major cause of irreversible vision loss in many developed countries. The most common cause of CNV is age-related macular degeneration but it may also occur secondary to a variety of other aetiologies such as pathological myopia, ocular histoplasmosis syndrome and angioid streaks.
This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.